Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
1995-12-1
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0038-4348
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
88
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1182-3
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:7482002-Antifibrinolytic Agents,
pubmed-meshheading:7482002-Female,
pubmed-meshheading:7482002-Fibrin Fibrinogen Degradation Products,
pubmed-meshheading:7482002-HELLP Syndrome,
pubmed-meshheading:7482002-Humans,
pubmed-meshheading:7482002-Pre-Eclampsia,
pubmed-meshheading:7482002-Pregnancy,
pubmed-meshheading:7482002-Pregnancy Outcome,
pubmed-meshheading:7482002-Sensitivity and Specificity
|
pubmed:year |
1995
|
pubmed:articleTitle |
D-dimer test for HELLP syndrome.
|
pubmed:publicationType |
Letter,
Comment
|